ReNeuron Group plc RENE.L Stock
ReNeuron Group plc Price Chart
ReNeuron Group plc RENE.L Financial and Trading Overview
| ReNeuron Group plc stock price | 3.38 GBP |
| Previous Close | 7.75 GBP |
| Open | 0 GBP |
| Bid | 7.8 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 33 GBP |
| Volume | 45.34K GBP |
| Avg. Volume | 231.81K GBP |
| Market Cap | 4.66M GBP |
| Beta (5Y Monthly) | 1.07816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 72 GBP |
RENE.L Valuation Measures
| Enterprise Value | -2301962 GBP |
| Trailing P/E | N/A |
| Forward P/E | 0.014298246 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 8.791819 |
| Price/Book (mrq) | 92.61363 |
| Enterprise Value/Revenue | -4.343 |
| Enterprise Value/EBITDA | 0.331 |
Trading Information
ReNeuron Group plc Stock Price History
| Beta (5Y Monthly) | 1.07816 |
| 52-Week Change | -73.45% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 33 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 7.76 GBP |
| 200-Day Moving Average | 14.88 GBP |
RENE.L Share Statistics
| Avg. Volume (3 month) | 231.81K GBP |
| Avg. Daily Volume (10-Days) | 598.6K GBP |
| Shares Outstanding | 57.17M |
| Float | 46.27M |
| Short Ratio | N/A |
| % Held by Insiders | 19.96% |
| % Held by Institutions | 30.97% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1342.45% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -32.97% |
| Return on Equity (ttm) | -72.37% |
Income Statement
| Revenue (ttm) | 530K GBP |
| Revenue Per Share (ttm) | 0.009 GBP |
| Quarterly Revenue Growth (yoy) | -73.29% |
| Gross Profit (ttm) | N/A |
| EBITDA | -6945000 GBP |
| Net Income Avi to Common (ttm) | -5408000 GBP |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.15M GBP |
| Total Cash Per Share (mrq) | 0.13 GBP |
| Total Debt (mrq) | 421K GBP |
| Total Debt/Equity (mrq) | 8.33 GBP |
| Current Ratio (mrq) | 2.046 |
| Book Value Per Share (mrq) | 0.088 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7484000 GBP |
| Levered Free Cash Flow (ttm) | -6299375 GBP |
Profile of ReNeuron Group plc
| Country | United Kingdom |
| State | N/A |
| City | Pencoed |
| Address | Pencoed Business Park |
| ZIP | CF35 5HY |
| Phone | 44 20 3819 8400 |
| Website | https://www.reneuron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized packages of information released by CTX cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Q&A For ReNeuron Group plc Stock
What is a current RENE.L stock price?
ReNeuron Group plc RENE.L stock price today per share is 3.38 GBP.
How to purchase ReNeuron Group plc stock?
You can buy RENE.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ReNeuron Group plc?
The stock symbol or ticker of ReNeuron Group plc is RENE.L.
Which industry does the ReNeuron Group plc company belong to?
The ReNeuron Group plc industry is Biotechnology.
How many shares does ReNeuron Group plc have in circulation?
The max supply of ReNeuron Group plc shares is 571.74K.
What is ReNeuron Group plc Price to Earnings Ratio (PE Ratio)?
ReNeuron Group plc PE Ratio is now.
What was ReNeuron Group plc earnings per share over the trailing 12 months (TTM)?
ReNeuron Group plc EPS is -0.09 GBP over the trailing 12 months.
Which sector does the ReNeuron Group plc company belong to?
The ReNeuron Group plc sector is Healthcare.
ReNeuron Group plc RENE.L included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| FTSE AIM All-Share Index FTAI | 755.91 GBP 966.76 USD |
-0.38
|
— — | 755.91 GBP 966.76 USD | 763.17 GBP 976.05 USD | — - | — — |
- {{ link.label }} {{link}}